Skip to main content
. 2021 Sep 9;11:738477. doi: 10.3389/fonc.2021.738477

Figure 9.

Figure 9

The immune status difference between high-risk and low-risk HCC patients. (A) Comparison of immune cell abundance between the high-risk and low-risk groups of HCC patients. (B) Comparison of immune-related functions between the high-risk and low-risk groups of HCC patients. (C) Comparison of the expression of immune checkpoints between the high- and low-risk groups. (D) Comparison of the expression of m6A-associated genes between the high- and low-risk groups. *P < 0.05; **P < 0.01; ***P < 0.001. ns, no significance.